These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17194501)

  • 1. PYY and the pancreas: inhibition of tumor growth and inflammation.
    Vona-Davis L; McFadden DW
    Peptides; 2007 Feb; 28(2):334-8. PubMed ID: 17194501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide YY mediates inhibition of tumor growth and inflammation.
    Alosi JA; McFadden DW
    Methods Mol Biol; 2009; 512():377-94. PubMed ID: 19347290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide YY reverses TNF-alpha induced transcription factor binding of interferon regulatory factor-1 and p53 in pancreatic acinar cells.
    Rizvi IA; Robinson K; McFadden DW; Riggs DR; Jackson BJ; Vona-Davis L
    J Surg Res; 2006 Nov; 136(1):25-30. PubMed ID: 16978650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth.
    Heisler T; Towfigh S; Simon N; Liu C; McFadden DW
    J Surg Res; 2000 Jan; 88(1):23-5. PubMed ID: 10644462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide YY exhibits a mitogenic effect on pancreatic cells while improving acute pancreatitis in vitro.
    Kazanjian KK; Towfigh S; McFadden DW
    J Surg Res; 2003 Sep; 114(1):95-9. PubMed ID: 13678704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1.
    Liu CD; Balasubramaniam A; Saxton RE; Paiva M; McFadden DW
    J Surg Res; 1995 Jun; 58(6):707-12. PubMed ID: 7791350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uroguanylin inhibits proliferation of pancreatic cancer cells.
    Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
    Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY induces intestinal proliferation in peptide YY knockout mice with total enteral nutrition after massive small bowel resection.
    Zhu W; Zhang W; Gong J; Huang Q; Shi Y; Li Q; Li N; Li J
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):517-25. PubMed ID: 19367178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide YY inhibits growth of human breast cancer in vitro and in vivo.
    Grisé KR; Rongione AJ; Laird EC; McFadden DW
    J Surg Res; 1999 Apr; 82(2):151-5. PubMed ID: 10090823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptide YY analog binds to a cell membrane receptor and delivers fluorescent dye to pancreatic cancer cells.
    Liu CD; Kwan D; Simon N; McFadden DW
    J Gastrointest Surg; 2001; 5(2):147-52. PubMed ID: 11331476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels.
    Liu CD; Slice LW; Balasubramaniam A; Walsh JH; Newton TR; Saxton RE; McFadden DW
    Surgery; 1995 Aug; 118(2):229-35; discussion 235-6. PubMed ID: 7638738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of peptide YY in regulating glucose homeostasis.
    Boey D; Sainsbury A; Herzog H
    Peptides; 2007 Feb; 28(2):390-5. PubMed ID: 17210210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells.
    Wang Y; Sternfeld L; Yang F; Rodriguez JA; Ross C; Hayden MR; Carriere F; Liu G; Hofer W; Schulz I
    Gut; 2009 Mar; 58(3):422-30. PubMed ID: 18936103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide YY and cancer: current findings and potential clinical applications.
    Tseng WW; Liu CD
    Peptides; 2002 Feb; 23(2):389-95. PubMed ID: 11825654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells.
    Heisler T; Towfigh S; Simon N; McFadden DW
    J Surg Res; 2000 Jun; 91(1):9-14. PubMed ID: 10816343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide YY(3-36)-induced inhibition of food intake in female monkeys.
    Papadimitriou MA; Krzemien AA; Hahn PM; Van Vugt DA
    Brain Res; 2007 Oct; 1175():60-5. PubMed ID: 17870058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slowing intestinal transit by PYY depends on serotonergic and opioid pathways.
    Lin HC; Neevel C; Chen JH
    Am J Physiol Gastrointest Liver Physiol; 2004 Apr; 286(4):G558-63. PubMed ID: 15010361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into alcoholic pancreatitis and pancreatic cancer.
    Apte M; Pirola R; Wilson J
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S51-6. PubMed ID: 19799699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of PYY in feeding regulation.
    Ueno H; Yamaguchi H; Mizuta M; Nakazato M
    Regul Pept; 2008 Jan; 145(1-3):12-6. PubMed ID: 17920705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulating effects of arsenic trioxide on cell death pathways and inflammatory reactions of pancreatic acinar cells in rats.
    Xue DB; Zhang WH; Yun XG; Song C; Zheng B; Shi XY; Wang HY
    Chin Med J (Engl); 2007 Apr; 120(8):690-5. PubMed ID: 17517186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.